Breaking News Instant updates and real-time market news.

2022-05-18 08:20:51 PPBT Purple Biotech $2.90 / + (+0.00%) , BMY Bristol-Myers $78.20 / +1.26 (+1.64%) 08:20 05/18/22 05/18 08:20 05/18/22 08:20	Purple Biotech announces initiation of Phase 2 study for CM24 Purple Biotech (PPBT) announced the initiation of the Phase 2 portion of its ongoing study of CM24, a first-in-class monoclonal antibody with the potential to treat multiple cancers. The Phase 2 is an open-label, multicenter study in subjects with metastatic pancreatic cancer, PDAC, to evaluate the safety and tolerability of CM24 in combination with the PD-1 inhibitor Opdivo and chemotherapy. The primary study endpoint is to evaluate preliminary efficacy in 2nd line PDAC. The phase 2 portion of the study is being conducted as part of Purple Biotech's clinical collaboration with Bristol Myers Squibb (BMY). The companies together made the determination to prioritize PDAC over non-small cell lung cancer based on the positive interim data. Accordingly, this decision will allow an increase in the number of subjects that will be participating, and will accelerate this part of the study, and the updated timeline to complete this trial is within 2023. "We are thrilled at the progress being made to help move this treatment forward in the clinical trial process for the potential benefit of patients with pancreatic cancer," said Gil Efron, President and CFO of Purple Biotech. "We are thankful for our partners at BMS for collaborating with us on this study and their support. Importantly, the decision to prioritize the PDAC study will extend the cash runway of Purple Biotech through the end of 2024," added Efron. PPBT Purple Biotech $2.90 / + (+0.00%) BMY Bristol-Myers $78.20 / +1.26 (+1.64%)	28 May 28 May 01 Jun 03 Jun 27 Jul 10 Sep

2022-05-18 08:20:51

PPBT

Purple Biotech

$2.90 / + (+0.00%)

, BMY

Bristol-Myers

$78.20 / +1.26 (+1.64%)

08:20

05/18/22

05/18

08:20

05/18/22

08:20

Purple Biotech announces initiation of Phase 2 study for CM24

Purple Biotech (PPBT) announced the initiation of the Phase 2 portion of its ongoing study of CM24, a first-in-class monoclonal antibody with the potential to treat multiple cancers. The Phase 2 is an open-label, multicenter study in subjects with metastatic pancreatic cancer, PDAC, to evaluate the safety and tolerability of CM24 in combination with the PD-1 inhibitor Opdivo and chemotherapy. The primary study endpoint is to evaluate preliminary efficacy in 2nd line PDAC. The phase 2 portion of the study is being conducted as part of Purple Biotech's clinical collaboration with Bristol Myers Squibb (BMY). The companies together made the determination to prioritize PDAC over non-small cell lung cancer based on the positive interim data. Accordingly, this decision will allow an increase in the number of subjects that will be participating, and will accelerate this part of the study, and the updated timeline to complete this trial is within 2023. "We are thrilled at the progress being made to help move this treatment forward in the clinical trial process for the potential benefit of patients with pancreatic cancer," said Gil Efron, President and CFO of Purple Biotech. "We are thankful for our partners at BMS for collaborating with us on this study and their support. Importantly, the decision to prioritize the PDAC study will extend the cash runway of Purple Biotech through the end of 2024," added Efron.

PPBT

Purple Biotech

$2.90 / + (+0.00%)

BMY

Bristol-Myers

$78.20 / +1.26 (+1.64%)

28
May
28
May
01
Jun
03
Jun
27
Jul
10
Sep

OTHER BREAKING NEWS FROM THE FLY

Recommendations	Mirati Therapeutics price target lowered to $127 from $208 at Citi » 06:31 07/07/22 07/07 06:31 07/07/22 06:31 MRTX Mirati Therapeutics $69.87 / -2.08 (-2.89%) Citi analyst Yigal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events MRTX Mirati Therapeutics $69.87 / -2.08 (-2.89%) 06/06/22 Mirati Therapeutics announces results from Phase 1b cohort of KRYSTAL-1 05/27/22 Mirati Therapeutics trading resumes 05/27/22 Mirati Therapeutics trading halted, volatility trading pause 05/26/22 Mirati Therapeutics says disease control rate was 80% in study MRTX Mirati Therapeutics $69.87 / -2.08 (-2.89%) 06/07/22 Stifel Mirati Therapeutics price target raised to $111 from $105 at Stifel 06/07/22 JMP Securities Mirati Therapeutics upgraded to Outperform from Market Perform at JMP Securities 05/27/22 Stifel Mirati Therapeutics after-hours move lower 'overdone,' says Stifel 05/20/22 Guggenheim Guggenheim upgrades Mirati to Buy on adagrasib's 'highly competitive profile' MRTX Mirati Therapeutics $69.87 / -2.08 (-2.89%) 02/28/22 Mirati Therapeutics reports Q4 EPS ($3.72), consensus ($3.00) 02/28/22 Mirati Therapeutics reports Q4 EPS ($3072), consensus ($3.00) 11 Nov MRTX Mirati Therapeutics $69.87 / -2.08 (-2.89%) 06/07/22 What You Missed On Wall Street On Tuesday 06/07/22 What You Missed On Wall Street This Morning 06/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/27/22 What You Missed On Wall Street On Friday 08/15/22 2022 Biotech Summer Summit 12/14/22 PDUFA Date for Adagrasib
Downgrade	FS Bancorp downgraded to Market Perform from Outperform at Raymond James » 06:29 07/07/22 07/07 06:29 07/07/22 06:29 FSBW FS Bancorp $28.95 / -0.09 (-0.31%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings FSBW FS Bancorp $28.95 / -0.09 (-0.31%) 04/06/22 FS Bancorp announces 10c per share special dividend, additional $10M to buyback 01/27/22 FS Bancorp raises quarterly dividend to 20c from 15c per share FSBW FS Bancorp $28.95 / -0.09 (-0.31%) 04/28/22 FS Bancorp reports Q1 EPS 81c, consensus 71c 01/27/22 FS Bancorp reports Q4 EPS $1.01, consensus 85c
Initiation	CTI BioPharma initiated with an Outperform at Cowen » 06:29 07/07/22 07/07 06:29 07/07/22 06:29 CTIC CTI BioPharma $6.01 / -0.235 (-3.76%) Cowen analyst Boris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CTIC CTI BioPharma $6.01 / -0.235 (-3.76%) 06/10/22 CTI BioPharma presents data from pacritinib program at EHA 05/26/22 CTI BioPharma to present pivotal data on pacritinib program 04/14/22 CTI BioPharma's Vonjo included in NCCN Myeloproliferative Neoplasm guidelines 02/28/22 CTI BioPharma announces FDA accelerated approval of VONJO CTIC CTI BioPharma $6.01 / -0.235 (-3.76%) 04/14/22 Stifel Stifel reiterates Buy on CTI BioPharma following new treatment guidelines 03/01/22 Brookline CTI BioPharma price target raised to $12 from $7.20 at Brookline 12/01/21 Lake Street CTI BioPharma delay creates buying opportunity, says Lake Street 10/04/21 Lake Street CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street CTIC CTI BioPharma $6.01 / -0.235 (-3.76%) 05/12/22 CTI BioPharma reports Q1 EPS (23c), consensus (41c) 03/31/22 CTI BioPharma reports Q4 EPS (38c), consensus (28c) CTIC CTI BioPharma $6.01 / -0.235 (-3.76%) 06/27/22 Fly Insider: American Woodmark, Coursera among week's notable insider trades 05/13/22 What You Missed On Wall Street On Friday 05/13/22 What You Missed On Wall Street This Morning 04/01/22 What You Missed On Wall Street On Friday 08/08/22 Biotechnology Conference 08/15/22 2022 Biotech Summer Summit CTIC CTI BioPharma $6.01 / -0.235 (-3.76%) 05/12/22 CTI BioPharma options imply 10.5% move in share price post-earnings 04/18/22 Unusually active option classes on open April 18th 03/31/22 CTI BioPharma options imply 5.3% move in share price post-earnings 03/24/22 CTI BioPharma options imply 7.9% move in share price post-earnings
Downgrade	CytomX Therapeutics downgraded to Neutral from Outperform at Wedbush » 06:28 07/07/22 07/07 06:28 07/07/22 06:28 CTMX CytomX Therapeutics $1.96 / +0.015 (+0.77%) Wedbush analyst Robert… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CTMX CytomX Therapeutics $1.96 / +0.015 (+0.77%) 07/06/22 CytomX Therapeutics trading resumes 07/06/22 CytomX Therapeutics to resume trading at 4:35 pm ET 07/06/22 CytomX reports Arm A of praluzatamab ravtansine trial met primary endpoint 07/06/22 CytomX Therapeutics trading halted, news pending CTMX CytomX Therapeutics $1.96 / +0.015 (+0.77%) 06:14 Today Barclays CytomX Therapeutics price target lowered to $3.50 from $7 at Barclays 04:44 Today Mizuho CytomX Therapeutics downgraded to Neutral from Buy at Mizuho 04:42 Today Piper Sandler CytomX Therapeutics downgraded to Neutral from Overweight at Piper Sandler 06/23/22 BMO Capital CytomX Therapeutics initiated with an Outperform at BMO Capital CTMX CytomX Therapeutics $1.96 / +0.015 (+0.77%) 03/01/22 CytomX Therapeutics reports Q4 revenue $19.7M, consensus $24.51M CTMX CytomX Therapeutics $1.96 / +0.015 (+0.77%) 07/06/22 Fly Intel: After-Hours Movers 08/08/22 Biotechnology Conference
Recommendations	Iveric bio price target raised to $30 from $25 at Morgan Stanley » 06:28 07/07/22 07/07 06:28 07/07/22 06:28 ISEE Iveric bio $10.44 / +0.3 (+2.96%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events ISEE Iveric bio $10.44 / +0.3 (+2.96%) 07/06/22 Iveric bio, DelSiTech announce Zimura global license agreement 07/05/22 Iveric bio, DelSiTech in pact to develop sustained release Zimura 06/14/22 Iveric bio director Roberts purchases 25K in company shares 06/10/22 Iveric announces presentation of post-hoc analysis from GATHER1 trial of zimura ISEE Iveric bio $10.44 / +0.3 (+2.96%) 06/08/22 Guggenheim Iveric bio initiated with a Buy at Guggenheim 06/08/22 BofA Iveric bio initiated with a Buy at BofA 05/12/22 B. Riley B. Riley puts Neutral rating on Iveric bio in 'contrarian call' 05/12/22 B. Riley Iveric bio initiated with a Neutral at B. Riley ISEE Iveric bio $10.44 / +0.3 (+2.96%) 05/04/22 Iveric bio reports Q1 EPS (29c), consensus (29c) 02/24/22 Iveric bio reports Q4 EPS (29c), consensus (24c) 22 Oct 13 Jul ISEE Iveric bio $10.44 / +0.3 (+2.96%) 05/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/21/22 Biopharma;Biotech 08/15/22 2022 Biotech Summer Summit
Recommendations	Warner Music price target lowered to $27 from $31 at Citi » 06:28 07/07/22 07/07 06:28 07/07/22 06:28 WMG Warner Music $25.03 / -0.6 (-2.34%) Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals WMG Warner Music $25.03 / -0.6 (-2.34%) 06/22/22 Warner Music confirms planning begun for CEO succession 03/21/22 Warner Music to acquire Qanawat Music 03/10/22 Warner Music suspends operations in Russia, including investments WMG Warner Music $25.03 / -0.6 (-2.34%) 07/05/22 Barclays Warner Music price target lowered to $33 from $37 at Barclays 06/03/22 Guggenheim Warner Music price target raised to $34 from $30 at Guggenheim 05/17/22 Citi Warner Music price target lowered to $31 from $41 at Citi 05/11/22 Barclays Warner Music price target lowered to $37 from $49 at Barclays WMG Warner Music $25.03 / -0.6 (-2.34%) 05/10/22 Warner Music reports Q2 EPS 18c, consensus 21c 05/09/22 Notable companies reporting before tomorrow's open 05/09/22 Notable companies reporting before tomorrow's open 02/08/22 Warner Music reports Q1 EPS 36c, consensus 29c 04 Jan 09 Dec 22 Sep 09 Sep WMG Warner Music $25.03 / -0.6 (-2.34%) 06/22/22 Warner Music CEO Steve Cooper to exit next year, WSJ reports
Recommendations	Warner Bros. Discovery price target lowered to $29 from $40 at Citi » 06:27 07/07/22 07/07 06:27 07/07/22 06:27 WBD Warner Bros. Discovery $14.26 / -0.195 (-1.35%) Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options WBD Warner Bros. Discovery $14.26 / -0.195 (-1.35%) 06/26/22 Fly Intel: Top five weekend stock stories 06/14/22 Bandai Namco's 'Elden Ring' back as best-selling game in U.S. in May, says NPD 06/02/22 Warner Bros. Pictures Group names De Luca, Abdy co-chairpersons, CEOs 05/13/22 'LEGO Star Wars' was best-selling game in April in U.S., says NPD WBD Warner Bros. Discovery $14.26 / -0.195 (-1.35%) 06/29/22 Benchmark Benchmark starts Warner Bros. Discovery at Buy, expects shares to recover 06/29/22 Benchmark Warner Bros. Discovery initiated with a Buy at Benchmark 06/16/22 JPMorgan Warner Bros. Discovery reinstated with a Neutral at JPMorgan 06/02/22 Wolfe Research Warner Bros. Discovery price target lowered to $20 from $30 at Wolfe Research WBD Warner Bros. Discovery $14.26 / -0.195 (-1.35%) 04/26/22 Warner Bros. Discovery reports Q1 diluted EPS 69c vs. 21c a year ago WBD Warner Bros. Discovery $14.26 / -0.195 (-1.35%) 06/29/22 Nexstar near to closing deal to acquire majority control of CW Network, WSJ says 06/14/22 Warner Bros. Discovery to lay off up to 30% of ad sales force, Information says 05/18/22 Warner Bros. Discovery moves several CNN+ shows to HBO Max, CNN, TechCrunch says 05/16/22 'Switch Sports' top U.K. boxed game seller again, Gamesindustry.biz says WBD Warner Bros. Discovery $14.26 / -0.195 (-1.35%) 07/04/22 Box Office Battle: ‘Minions: The Rise of Gru’ wins weekend with record debut 06/26/22 Box Office Battle: ‘Elvis’ ties with ‘Top Gun: Maverick’ for top spot 06/20/22 Box Office Battle: ‘Jurassic World Dominion’ wins Father’s Day weekend 06/16/22 What You Missed On Wall Street On Thursday WBD Warner Bros. Discovery $14.26 / -0.195 (-1.35%) 06/23/22 Unusually active option classes on open June 23rd 06/13/22 Warner Bros Discovery Inc put volume heavy and directionally bearish 04/14/22 Notable open interest changes for April 14th 04/13/22 Notable open interest changes for April 13th
Recommendations	Disney price target lowered to $145 from $165 at Citi » 06:27 07/07/22 07/07 06:27 07/07/22 06:27 DIS Disney $96.07 / -1.15 (-1.18%) Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DIS Disney $96.07 / -1.15 (-1.18%) 06/28/22 Disney board unanimously votes to extend CEO Chapek's contract by three years 06/16/22 Mattel appoints Josh Silverman as Chief Franchise Officer 06/09/22 Take-Two's 'Marvel's Midnight Suns' out October 7, 2022 06/09/22 Disney names Dana Walden as Chairman of Disney General Entertainment Content DIS Disney $96.07 / -1.15 (-1.18%) 07/05/22 Vertical Group Disney downgraded to Mixed from Positive at Vertical Group 06/30/22 Morgan Stanley Disney price target lowered to $125 from $170 at Morgan Stanley 06/15/22 Evercore ISI Disney showing good financial discipline with IPL renewal, says Evercore ISI 06/06/22 Deutsche Bank Disney price target lowered to $130 from $191 at Deutsche Bank DIS Disney $96.07 / -1.15 (-1.18%) 05/11/22 Disney reports Q2 EPS ex-items $1.08, consensus $1.17 05/11/22 Notable companies reporting after market close 02/09/22 Disney reports Q1 EPS ex-items $1.06, consensus 57c 02/09/22 Notable companies reporting after market close DIS Disney $96.07 / -1.15 (-1.18%) 06/28/22 Disney to reopen Shanghai Disneyland on June 30, Bloomberg says 06/24/22 Disney, Apple, Amazon bid on NFL's Sunday Ticket, CNBC reports 06/24/22 F1 renews U.S. media rights deal with ESPN through 2025, SBJ reports 06/24/22 Disney to cover travel expenses for reproductive care for staff, Reuters says DIS Disney $96.07 / -1.15 (-1.18%) 07/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/04/22 Box Office Battle: ‘Minions: The Rise of Gru’ wins weekend with record debut 06/29/22 What You Missed On Wall Street On Wednesday 06/29/22 What You Missed On Wall Street This Morning 08/10/22 Disney - DIS DIS Disney $96.07 / -1.15 (-1.18%) 05/11/22 Disney options imply 8.5% move in share price post-earnings 05/09/22 Unusually active option classes on open May 9th 04/20/22 Unusually active option classes on open April 20th 02/10/22 Early notable gainers among liquid option names on February 10th
Recommendations	Vivid Seats price target lowered to $12 from $14 at Citi » 06:27 07/07/22 07/07 06:27 07/07/22 06:27 SEAT Vivid Seats $7.55 / -0.43 (-5.39%) Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SEAT Vivid Seats $7.55 / -0.43 (-5.39%) 06/30/22 Vivid Seats announces expiration, results of exchange offer 06/16/22 Vivid Seats to join Russell 2000, Russell 3000 Indexes 05/26/22 Vivid Seats board authorizes $40M share repurchase program 05/26/22 Vivid Seats announces exchange offer, consent solicitation SEAT Vivid Seats $7.55 / -0.43 (-5.39%) 05/10/22 Raymond James Vivid Seats price target lowered to $11 from $17 at Raymond James 03/11/22 Benchmark Vivid Seats price target lowered to $17 from $19 at Benchmark 01/31/22 Credit Suisse Vivid Seats initiated with an Outperform at Credit Suisse 01/03/22 Citi Citi upgrades Vivid Seats to Buy on 'unwarranted' selloff SEAT Vivid Seats $7.55 / -0.43 (-5.39%) 05/10/22 Vivid Seats raises FY22 revenue view to $520.0M-$555.0M from $510.0M-$550.0M 05/10/22 Vivid Seats reports Q1 revenue $130.8M, consensus $113.83M 03/10/22 Vivid Seats sees 2022 revenue $510M-$550M, consensus $554.44M 03/10/22 Vivid Seats reports Q4 revenue $163.9M, consensus $139.54M 09/08/22 Consumer/Media/Entertainment Conference
Recommendations	Unity Software price target lowered to $68 from $71 at Citi » 06:27 07/07/22 07/07 06:27 07/07/22 06:27 U Unity Software / + Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options U Unity Software / + 06/08/22 Cathie Wood's ARK Investment bought 232.6K shares of Unity Software today 05/12/22 Cathie Wood's ARK Investment bought 331.6K shares of Unity Software today 05/12/22 Unity Software trading resumes 05/12/22 Unity Software trading halted, volatility trading pause U Unity Software / + 06/30/22 KeyBanc Unity Software initiated with a Sector Weight at KeyBanc 06/29/22 BTIG Unity Software price target lowered to $72 from $110 at BTIG 06/21/22 Credit Suisse Unity Software price target lowered to $105 from $137 at Credit Suisse 06/16/22 Jefferies Unity Software price target lowered to $36 from $40 at Jefferies U Unity Software / + 05/10/22 Unity Software cuts FY22 revenue view to $1.35B-$1.425B, consensus $1.5B 05/10/22 Unity Software sees Q2 revenue $290M-$295M, consensus $360.97M 05/10/22 Unity Software reports Q1 adjusted EPS (8c), consensus (8c) 05/10/22 Notable companies reporting after market close U Unity Software / + 06/29/22 Unity lays off hundreds of workers, Kotaku reports U Unity Software / + 06/30/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/16/22 What You Missed On Wall Street On Thursday 06/16/22 What You Missed On Wall Street This Morning 05/11/22 What You Missed On Wall Street On Wednesday U Unity Software / + 06/16/22 Unity Software call volume above normal and directionally bullish 05/19/22 Unity Software call volume above normal and directionally bullish 05/10/22 Unity Software options imply 17.8% move in share price post-earnings 04/22/22 Unity Software call volume above normal and directionally bullish

Recommendations	Spotify price target lowered to $150 from $165 at Citi » 06:27 07/07/22 07/07 06:27 07/07/22 06:27 SPOT Spotify / + Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SPOT Spotify / + 06/23/22 Spotify introduces new Live Events Feed, replacing Concert Hub 06/21/22 Obama's media company, Amazon's Audible announce exclusive first look deal 06/15/22 Integral Ad Science and Spotify partner for podcast advertising solution 06/13/22 Spotify to acquire AI voice platform Sonantic; financial terms not disclosed SPOT Spotify / + 06/29/22 JPMorgan Spotify price target lowered to $145 from $150 at JPMorgan 06/15/22 Wells Fargo Wells Fargo upgrades Spotify to Equal Weight, raises price target to $124 06/15/22 Wells Fargo Spotify upgraded to Equal Weight from Underweight at Wells Fargo 06/09/22 Goldman Sachs Spotify price target lowered to $133 from $150 at Goldman Sachs SPOT Spotify / + 04/27/22 Spotify sees Q2 revenue EUR 2.8B, MAUs 428M 04/27/22 Spotify reports Q1 EPS EUR 0.21 vs. (EUR 0.25) last year 02/02/22 Spotify reports Q4 EPS (EUR0.21) vs (EUR0.66) last year SPOT Spotify / + 06/15/22 Spotify CEO says will slow hiring by 25%, Bloomberg reports 06/15/22 Spotify CEO says will slow hiring by 25%, Bloomberg reports 05/16/22 Spotify tells TechCrunch it is testing feature to let artists promote NFTs 05/12/22 Spotify promotes Bill Simmons to oversee global sports strategy, Verge reports SPOT Spotify / + 06/15/22 What You Missed On Wall Street On Wednesday 06/15/22 What You Missed On Wall Street This Morning 06/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/15/22 Fly Intel: Pre-market Movers 07/27/22 Spotify - SPOT SPOT Spotify / + 06/29/22 Spotify call volume above normal and directionally bullish 04/21/22 Spotify put volume heavy and directionally bearish 02/10/22 Spotify call buyer realizes 37% same-day gains 02/02/22 Spotify options imply 11.1% move in share price post-earnings
Downgrade	Veritex downgraded to Outperform from Strong Buy at Raymond James » 06:26 07/07/22 07/07 06:26 07/07/22 06:26 VBTX Veritex / + Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate VBTX Veritex / + 03/09/22 Veritex director Arcilia Acosta acquires 26,316 common shares 03/09/22 Veritex director Pat Bolin acquires 13,158 common shares 03/03/22 Veritex commences common stock offering 03/03/22 Veritex to acquire interLink in $91M cash and stock transaction VBTX Veritex / + 06/13/22 DA Davidson DA Davidson says recent and pending investments by Veritex support tailwinds 01/27/22 Raymond James Veritex price target raised to $49 from $46 at Raymond James 10/28/21 Piper Sandler Veritex price target raised to $46 from $42 at Piper Sandler 09/22/21 DA Davidson Veritex price target raised to $44 from $40 at DA Davidson 04 Mar
Recommendations	Sportradar price target lowered to $18 from $23 at Citi » 06:26 07/07/22 07/07 06:26 07/07/22 06:26 SRAD Sportradar $7.93 / -0.39 (-4.69%) Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly SRAD Sportradar $7.93 / -0.39 (-4.69%) 06/08/22 Sportradar appoints Eric Conrad as MD, strategic partnerships, content 04/11/22 Sportradar announces acquisition of Vaix Limited 04/05/22 Sportradar awarded supplier registration for online/mobile wagering in Ontario 02/15/22 Sportradar enters multi-year agreement with USFL SRAD Sportradar $7.93 / -0.39 (-4.69%) 05/19/22 Benchmark Sportradar price target lowered to $15 from $30 at Benchmark 05/19/22 Craig-Hallum Sportradar price target lowered to $25 from $30 at Craig-Hallum 05/19/22 JPMorgan Sportradar price target lowered to $14 from $24 at JPMorgan 05/19/22 Deutsche Bank Sportradar price target lowered to $13 from $20 at Deutsche Bank SRAD Sportradar $7.93 / -0.39 (-4.69%) 05/18/22 Sportradar reaffirms FY22 revenue view EUR 665M - EUR 700M 05/18/22 Sportradar reports Q1 revenue EUR 167.9M vs EUR 128.471M last year 03/30/22 Sportradar sees FY22 revenue EUR 665M - EUR 700M 03/30/22 Sportradar reports Q4 revenue EUR 152.37M vs EUR 108.03M last year 14 Sep SRAD Sportradar $7.93 / -0.39 (-4.69%) 05/20/22 Bet On It: Kansas legalizes sports betting, aims to launch early 04/22/22 Bet On It: Maine sports betting legislation has one stop before Governor's desk 04/08/22 Bet On It: Ontario launch sends operators flocking to Great White North 02/18/22 Bet On It: DraftKings cites unstable stock market for post-earnings dip
Recommendations	Skillz price target lowered to $1.55 from $2.10 at Citi » 06:26 07/07/22 07/07 06:26 07/07/22 06:26 SKLZ Skillz $1.37 / -0.02 (-1.44%) Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options SKLZ Skillz $1.37 / -0.02 (-1.44%) 06/30/22 Skillz appoints Jason Roswig as CFO 03/23/22 Skillz announces multiyear partnership with UFC SKLZ Skillz $1.37 / -0.02 (-1.44%) 05/23/22 Citi Skillz downgraded to Neutral from Buy at Citi 03/01/22 Citi Skillz price target lowered to $5 from $9 at Citi 02/24/22 Stifel Skillz price target lowered to $3.50 from $16 at Stifel 02/24/22 Wedbush Skillz price target lowered to $7.50 from $25 at Wedbush SKLZ Skillz $1.37 / -0.02 (-1.44%) 05/04/22 Skillz sees FY22 revenue view $400M, consensus $399.24M 05/04/22 Skillz reports Q1 EPS (37c), consensus (18c) 02/23/22 Skillz sees FY22 revenue $400M, consensus $548.8M 02/23/22 Skillz reports Q4 EPS (25c), consensus (15c) SKLZ Skillz $1.37 / -0.02 (-1.44%) 02/23/22 Fly Intel: After-Hours Movers SKLZ Skillz $1.37 / -0.02 (-1.44%) 05/04/22 Skillz options imply 19.9% move in share price post-earnings 02/23/22 Skillz options imply 20.8% move in share price post-earnings 01/11/22 Skillz call volume above normal and directionally bullish
Recommendations	Sirius XM price target lowered to $7.50 from $7.60 at Citi » 06:26 07/07/22 07/07 06:26 07/07/22 06:26 SIRI Sirius XM $6.19 / -0.02 (-0.32%) Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options SIRI Sirius XM $6.19 / -0.02 (-0.32%) 05/23/22 Sirius XM announces acquisition of Team Coco 05/05/22 Sirius XM, Formula 1 announce multi-year extension 04/26/22 Sirius XM to cover the 2022 NFL Draft 04/19/22 Sirius XM announces quarterly dividend of 2.1961c per share SIRI Sirius XM $6.19 / -0.02 (-0.32%) 04/19/22 Rosenblatt Sirius XM initiated with a Buy at Rosenblatt 04/19/22 Rosenblatt Liberty Sirius XM initiated with a Buy at Rosenblatt 04/18/22 Morgan Stanley Sirius XM downgraded to Underweight at Morgan Stanley amid auto headwinds 04/18/22 Morgan Stanley Sirius XM downgraded to Underweight from Equal Weight at Morgan Stanley SIRI Sirius XM $6.19 / -0.02 (-0.32%) 04/28/22 Sirius XM backs FY22 revenue view $9B, consensus $8.98B 04/28/22 Sirius XM reports Q1 EPS 8c, consensus 8c 04/27/22 Notable companies reporting before tomorrow's open 04/27/22 Notable companies reporting before tomorrow's open SIRI Sirius XM $6.19 / -0.02 (-0.32%) 04/28/22 Fly Intel: Pre-market Movers 04/18/22 What You Missed On Wall Street On Monday 04/18/22 What You Missed On Wall Street This Morning 04/18/22 Fly Intel: Pre-market Movers 07/28/22 Sirius XM - SIRI 08/09/22 Sirius XM 08/10/22 Sirius XM SIRI Sirius XM $6.19 / -0.02 (-0.32%) 06/28/22 Sirius XM put volume heavy and directionally bearish 05/27/22 Sirius XM call volume above normal and directionally bullish 05/05/22 Unusually active option classes on open May 5th 05/02/22 Largest borrow rate increases among liquid names
Downgrade	PNC Financial downgraded to Market Perform from Outperform at Raymond James » 06:26 07/07/22 07/07 06:26 07/07/22 06:26 PNC PNC Financial / + Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PNC PNC Financial / + 06/27/22 PNC Financial announces CCAR results 06/23/22 PNC Financial releases results of Dodd-Frank stress tests 06/21/22 Exela Technologies closes $150M securitization facility with PNC Bank 06/15/22 PNC Financial increases prime lending rate to 4.75% PNC PNC Financial / + 07/01/22 Oppenheimer Oppenheimer says U.S. financial institutions 'dramatically undervalued' 05/26/22 Wolfe Research PNC Financial price target lowered to $177 from $223 at Wolfe Research 04/18/22 Argus PNC Financial price target lowered to $220 from $245 at Argus 04/18/22 Raymond James PNC Financial price target lowered to $210 from $215 at Raymond James PNC PNC Financial / + 04/14/22 PNC Financial reports Q1 adjusted EPS $3.29, consensus $2.73 04/13/22 Notable companies reporting before tomorrow's open 04/13/22 Notable companies reporting before tomorrow's open 01/18/22 PNC Financial sees Q1 revenue down 3%-5%, consensus $5B PNC PNC Financial / + 04/14/22 Fly Intel: Pre-market Movers 04/13/22 Here's what Wall St. experts are saying about these banks ahead of earnings 01/18/22 Fly Intel: Wall Street's top stories for Tuesday 01/18/22 Wall Street in Fives - Must Read Lists at Midday 07/15/22 PNC Financial - PNC PNC PNC Financial / + 01/21/22 PNC Financial put volume heavy and directionally bearish
Recommendations	Roku price target lowered to $165 from $175 at Citi » 06:26 07/07/22 07/07 06:26 07/07/22 06:26 ROKU Roku $88.61 / -3.5 (-3.80%) Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ROKU Roku $88.61 / -3.5 (-3.80%) 06/23/22 Crackle launches updated app on Roku devices 06/21/22 Cathie Wood's ARK Investment bought 39.6K shares of Roku today 06/16/22 Roku jumps over 3% to $81.25 after announcing shopping deal with Walmart 06/16/22 Walmart to become exclusive partner for Roku for direct shopping on TV ROKU Roku $88.61 / -3.5 (-3.80%) 06/17/22 Truist Deal with Walmart an 'incremental positive' for Roku, says Truist 06/09/22 KeyBanc KeyBanc 'skeptical' of any Netflix, Roku deal 06/08/22 Benchmark Acquisition of Roku would be 'heroic departure' for Netflix, says Benchmark 06/08/22 Truist Truist sees 'industrial logic' to potential Netflix, Roku tie-up ROKU Roku $88.61 / -3.5 (-3.80%) 04/28/22 Roku backs FY22 revenue growth view of 35% y/y, consensus $3.72B 04/28/22 Roku sees Q2 revenue $805M, consensus $815.7M 04/28/22 Roku reports Q1 EPS (19c), consensus (18c) 04/28/22 Notable companies reporting after market close ROKU Roku $88.61 / -3.5 (-3.80%) 06/14/22 Netflix talked with Roku, Comcast about ad sales, The Information reports 06/08/22 Roku staff 'buzzing' about possibility of being bought by Netflix, Insider says 05/06/22 Microsoft working on Xbox Cloud streaming device for TVs, VentureBeat says 05/03/22 Roku, Apollo team to bid for minority stake in Starz, WSJ reports ROKU Roku $88.61 / -3.5 (-3.80%) 06/17/22 Fly Intel: Pre-market Movers 06/16/22 Fly Intel: After-Hours Movers 06/14/22 What You Missed On Wall Street On Tuesday 06/14/22 What You Missed On Wall Street This Morning 09/08/22 Consumer/Media/Entertainment Conference ROKU Roku $88.61 / -3.5 (-3.80%) 06/08/22 Unusually active option classes on open June 8th 05/25/22 Unusually active option classes on open May 25th 05/23/22 Roku put volume heavy and directionally bearish 04/28/22 Roku options imply 14.4% move in share price post-earnings
Recommendations	Roblox price target lowered to $46 from $52 at Citi » 06:25 07/07/22 07/07 06:25 07/07/22 06:25 RBLX Roblox $37.94 / -2.05 (-5.13%) Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options RBLX Roblox $37.94 / -2.05 (-5.13%) 07/01/22 Roblox rises 5.2% 06/15/22 Roblox reports May DAUs 50.4M, up 17% 06/14/22 Happy Nation launches first metaverse experience via Roblox integration 06/10/22 Izea awarded $2.8M contract by global Fortune 20 technology company RBLX Roblox $37.94 / -2.05 (-5.13%) 06/17/22 Truist Roblox downgraded to Hold from Buy at Truist 06/16/22 MKM Partners Roblox price target lowered to $28 from $30 at MKM Partners 06/16/22 Morgan Stanley Roblox price target lowered to $25 from $27 at Morgan Stanley 06/15/22 Stifel Roblox price target lowered to $40 from $45 at Stifel RBLX Roblox $37.94 / -2.05 (-5.13%) 05/10/22 Roblox reports Q1 EPS (27c), consensus (21c) 05/10/22 Notable companies reporting after market close 02/15/22 Roblox reports Q4 EPS (25c), consensus (13c) 02/15/22 Notable companies reporting after market close RBLX Roblox $37.94 / -2.05 (-5.13%) 04/06/22 Meta plans to introduce virtual coins for the metaverse, FT reports 02/03/22 Roblox mentioned cautiously by Bear Cave's Dorsey RBLX Roblox $37.94 / -2.05 (-5.13%) 06/17/22 What You Missed On Wall Street On Friday 06/17/22 What You Missed On Wall Street This Morning 06/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/15/22 What You Missed On Wall Street On Wednesday RBLX Roblox $37.94 / -2.05 (-5.13%) 07/06/22 Unusually active option classes on open July 6th 06/24/22 Unusually active option classes on open June 24th 05/13/22 Unusually active option classes on open May 13th 05/10/22 Roblox options imply 24.4% move in share price post-earnings
Upgrade	Texas Capital upgraded to Strong Buy from Outperform at Raymond James » 06:25 07/07/22 07/07 06:25 07/07/22 06:25 TCBI Texas Capital $53.10 / -0.25 (-0.47%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options TCBI Texas Capital $53.10 / -0.25 (-0.47%) 04/20/22 Regulatory ratios in excess of 'well-capitalized' requirements as of March 31 02/22/22 Texas Capital partners with Huston-Tillotson University 02/09/22 Bask Bank expands product set with high-yield interest savings account 01/20/22 Texas Capital names John Cummings EVP, Chief Administrative Officer TCBI Texas Capital $53.10 / -0.25 (-0.47%) 06/15/22 Truist Texas Capital price target lowered to $65 from $69 at Truist 01/18/22 BofA Texas Capital reinstated with a Neutral at BofA 09/02/21 Wedbush Texas Capital downgraded to Neutral at Wedbush 09/02/21 Janney Montgomery Scott Janney cuts Texas Capital to Neutral on longer than expected turnaround timeline TCBI Texas Capital $53.10 / -0.25 (-0.47%) 04/20/22 Texas Capital reports Q1 EPS 69c, consensus 73c TCBI Texas Capital $53.10 / -0.25 (-0.47%) 05/09/22 Fly Insider: Kennametal, Apple among notable insider trades this week 08/23/22 Texas Bank Summit TCBI Texas Capital $53.10 / -0.25 (-0.47%) 01/20/22 Texas Capital options imply 4.7% move in share price post-earnings
Recommendations	Qurate Retail price target lowered to $3 from $4 at Citi » 06:25 07/07/22 07/07 06:25 07/07/22 06:25 QRTEA Qurate Retail $2.63 / -0.34 (-11.45%) Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings QRTEA Qurate Retail $2.63 / -0.34 (-11.45%) 03/14/22 Qurate Retail names Terry Boyle as President & CEO of Zulily QRTEA Qurate Retail $2.63 / -0.34 (-11.45%) 02/28/22 BofA Qurate Retail cut to Neutral at BofA amid competitive and execution issues 02/28/22 BofA Qurate Retail downgraded to Neutral from Buy at BofA QRTEA Qurate Retail $2.63 / -0.34 (-11.45%) 05/06/22 Qurate Retail reports Q1 adjusted EPS 15c, consensus 25c 02/25/22 Qurate Retail reports Q4 EPS 40c, consensus 59c 01/28/22 Qurate Retail reports preliminary Q4 revenue down 8%-9%, consensus $4.34B

Recommendations	Playtika price target lowered to $15 from $17 at Citi » 06:25 07/07/22 07/07 06:25 07/07/22 06:25 PLTK Playtika $13.70 / -0.06 (-0.44%) Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PLTK Playtika $13.70 / -0.06 (-0.44%) 06/28/22 Joffre to purchase 106,102,467 Playtika shares at $21 per share 05/16/22 Playtika invests $5M in card game developer ProDrops 03/23/22 Playtika acquires JustPlay.LOL, terms not stated 02/24/22 Playtika to explore strategic alternatives PLTK Playtika $13.70 / -0.06 (-0.44%) 06/22/22 Cowen Playtika valuation attractive with strong fundamentals, says Cowen 05/12/22 Truist SciPlay upgraded to Buy from Hold at Truist 05/11/22 MKM Partners Playtika price target lowered to $17 from $25 at MKM Partners 05/11/22 Wedbush Playtika price target lowered to $22 from $35 at Wedbush PLTK Playtika $13.70 / -0.06 (-0.44%) 05/10/22 Playtika sees 2022 revenue $2.73B, consensus $2.82B 05/10/22 Playtika reports Q1 EPS 20c, consensus 22c 02/24/22 Playtika reports Q4 EPS 25c, consensus 17c PLTK Playtika $13.70 / -0.06 (-0.44%) 06/28/22 Joffre Capital to buy majority stake in Playtika at $21 per share, Axios reports 02/03/22 Playtika 'another piggy banks for Chinese insiders,' short-seller Grizzly says PLTK Playtika $13.70 / -0.06 (-0.44%) 06/28/22 What You Missed On Wall Street On Tuesday 06/28/22 What You Missed On Wall Street This Morning 06/28/22 Fly Intel: Pre-market Movers 04/19/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations PLTK Playtika $13.70 / -0.06 (-0.44%) 05/09/22 Playtika Holding Corp put volume heavy and directionally bearish 05/06/22 Playtika Holding Corp put volume heavy and directionally bearish 05/03/22 Largest borrow rate increases among liquid names
Downgrade	Hilltop Holdings downgraded to Underperform from Market Perform at Raymond James » 06:25 07/07/22 07/07 06:25 07/07/22 06:25 HTH Hilltop Holdings $27.43 / -0.35 (-1.26%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options HTH Hilltop Holdings $27.43 / -0.35 (-1.26%) 06/02/22 Hilltop Holdings reports final results of "Dutch auction" tender offer 05/31/22 Hilltop Holdings announces preliminary results of tender offer 05/02/22 Hilltop Holdings rises 18.0% 05/02/22 Hilltop Holdings rises 16.9% HTH Hilltop Holdings $27.43 / -0.35 (-1.26%) 07/26/21 Raymond James Hilltop Holdings downgraded to Market Perform from Outperform at Raymond James 07/26/21 Raymond James Hilltop Holdings downgraded to Market Perform from Outperform at Raymond James HTH Hilltop Holdings $27.43 / -0.35 (-1.26%) 04/21/22 Hilltop Holdings reports Q1 EPS 28c, consensus 53c 01/27/22 Hilltop Holdings reports Q4 EPS 78c, consensus 73c HTH Hilltop Holdings $27.43 / -0.35 (-1.26%) 05/02/22 What You Missed On Wall Street On Monday 05/02/22 What You Missed On Wall Street This Morning 04/21/22 Fly Intel: After-Hours Movers 07/21/22 Hilltop Holdings Inc. HTH Hilltop Holdings $27.43 / -0.35 (-1.26%) 06/02/22 Largest borrow rate increases among liquid names
Recommendations	Paramount price target lowered to $37 from $44 at Citi » 06:25 07/07/22 07/07 06:25 07/07/22 06:25 PARA Paramount $25.06 / -0.135 (-0.54%) Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PARA Paramount $25.06 / -0.135 (-0.54%) 06/26/22 Fly Intel: Top five weekend stock stories 06/21/22 Paramount+ intends to commission 150 international originals by 2025 06/13/22 AMC says past weekend admissions revenues 15% higher than same period in 2019 06/05/22 Fly Intel: Top five weekend stock stories PARA Paramount $25.06 / -0.135 (-0.54%) 07/06/22 BofA Paramount price target lowered to $28 from $32 at BofA 07/05/22 Vertical Group Paramount downgraded to Mixed from Positive at Vertical Group 07/01/22 Daiwa Paramount initiated with a Neutral at Daiwa 06/15/22 Evercore ISI Disney showing good financial discipline with IPL renewal, says Evercore ISI PARA Paramount $25.06 / -0.135 (-0.54%) 05/03/22 Paramount reports Q1 EPS 60c, consensus 51c 05/02/22 Notable companies reporting before tomorrow's open 05/02/22 Notable companies reporting before tomorrow's open PARA Paramount $25.06 / -0.135 (-0.54%) 06/29/22 Nexstar near to closing deal to acquire majority control of CW Network, WSJ says 06/15/22 Paramount's international chief goes 'on leave,' Deadline reports 06/13/22 Disney loses out to Paramount JV in bid for cricket streaming rights, NYT says 06/06/22 Paramount sued over rights to 'Top Gun' sequel, Reuters reports PARA Paramount $25.06 / -0.135 (-0.54%) 07/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/04/22 Box Office Battle: ‘Minions: The Rise of Gru’ wins weekend with record debut 07/01/22 What You Missed On Wall Street On Friday 07/01/22 What You Missed On Wall Street This Morning 09/08/22 Consumer/Media/Entertainment Conference 08/04/22 Paramount - PARA PARA Paramount $25.06 / -0.135 (-0.54%) 05/18/22 Paramount Global call volume above normal and directionally bullish 05/17/22 Early notable gainers among liquid option names on May 17th 05/17/22 Unusually active option classes on open May 17th 05/09/22 Paramount Global call volume above normal and directionally bullish
Downgrade	Guaranty Bancshares downgraded to Market Perform from Outperform at Raymond James » 06:24 07/07/22 07/07 06:24 07/07/22 06:24 GNTY Guaranty Bancshares $36.41 / +0.02 (+0.05%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events GNTY Guaranty Bancshares $36.41 / +0.02 (+0.05%) 05/04/22 Guaranty Bancshares announces 1M share repurchase program 03/10/22 Guaranty Bancshares increases dividend 10% to 22c per share GNTY Guaranty Bancshares $36.41 / +0.02 (+0.05%) 07/08/21 Raymond James Raymond James starts Guaranty at Outperform on Texas 'tailwinds' 07/08/21 Raymond James Guaranty Bancshares initiated with an Outperform at Raymond James GNTY Guaranty Bancshares $36.41 / +0.02 (+0.05%) 04/18/22 Guaranty Bancshares reports Q1 EPS 88c, consensus 69c 01/18/22 Guaranty Bancshares reports Q4 core EPS 84c, consensus 81c 07/18/22 Guaranty Bancshares - GNTY
Recommendations	Outfront Media price target lowered to $28 from $30 at Citi » 06:24 07/07/22 07/07 06:24 07/07/22 06:24 OUT Outfront Media / + Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly OUT Outfront Media / + 05/12/22 Outfront Media acquires billboard assets in Oregon, Washington OUT Outfront Media / + 06/10/22 Morgan Stanley Outfront Media price target lowered to $22 from $33 at Morgan Stanley 05/19/22 Citi Outfront Media price target lowered to $30 from $31 at Citi 03/29/22 Wolfe Research Outfront Media initiated with an Outperform at Wolfe Research 11/12/21 Citi Outfront Media price target raised to $31 from $28 at Citi OUT Outfront Media / + 05/02/22 Outfront Media reports Q1 EPS (4c), consensus (8c) 02/23/22 Outfront Media reports Q4 EPS 41c, consensus 24c OUT Outfront Media / + 03/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations

Events

Earnings calls, analyst events, roadshows and more

Today at 07:00

Challenger Job-Cut Report Level: June 2022 Government Event
Today at 08:15

ADP Employment Report: Private Payrolls M/M: June 2022 Government Event
Today at 08:30

Initial Jobless Claims Level: Week 7/2/2022 Government Event
Today at 08:30

Jobless Claims: 4-Week Moving Average: Week 7/2/2022 Government Event
Today at 08:30

International Trade in Goods and Services Balance: May 2022 Government Event
Today at 08:30

Initial Jobless Claims Change: Week 7/2/2022 Government Event
BYRN
Today at 09:00

Byrna Technologies - BYRN Conference Calls
HELE
Today at 09:00

Helen of Troy - HELE Conference Calls
NTIC
Today at 09:00

Northern Technologies - NTIC Conference Calls
SAR
Today at 10:00

Saratoga Investment - SAR Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	NAPA X NAPA Duckhorn Portfolio Spot Secondary Managers: Credit Suisse $20.73 5M Shares
Thurs	NCPL X NCPL Netcapital Secondary Managers: ThinkEquity $7.65 784K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Purple Biotech announces initiation of Phase 2 study for CM24

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access